Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 24, 2014

New Database Project Will Make MS Research Available to All

  • Additional MS resource sites
    /
A new database initiative will let doctors, researchers, and patients see real-time, real-world data about MS. A new open-source database…
Additional MS resource sites

October 24, 2014

CARE PARTNERS – The People Who Make a Difference in Our Lives

  • Caregiver related
    /
From the MSAA Care Partners: The People Who Make a Difference in Our Lives By Maryann B. HunsbergerThis article highlights…
Caregiver related

October 24, 2014

With Regards to Tecfidera

  • Oral MS Medications
    /
After the recent news of PML being found in a Tecfidera patient from Europe, a health care clinician wanted to…
Oral MS Medications

October 22, 2014

Biogen’s Tecfidera sales miss estimates; confirms first PML case

  • Oral MS Medications
    /
(Reuters) – Biogen Idec Inc said on Wednesday sales of its big-selling new multiple sclerosis drug Tecfidera fell short of…
Oral MS Medications

October 22, 2014

New Myelin Required to Learn a New Task

  • Myelin Repair
    /
Oct 17, 2014 Researchers have discovered that oligodendrocytes play an active role in learning motor tasks. Rodents whose oligodendrocyte precursor…
Myelin Repair

October 22, 2014

Some Astrocytes Appear to Promote Progressive MS

  • Multiple Sclerosis
    /
  • SPMS-PPMS News
    /
October 2014 Researchers have identified a key enzyme in astrocytes that turns on during the progressive stage of multiple sclerosis,…
Multiple Sclerosis

October 22, 2014

Vaccines Do Not Increase Risk of Multiple Sclerosis

  • MS Research Study and Reports
    /
October 20, 2014 Add one more condition to the list of things that vaccines don’t cause: multiple sclerosis. Scientists looked at about…
MS Research Study and Reports

October 21, 2014

RRMS and CIS—Baseline Characteristics

  • MS Research Study and Reports
    /
Clinical trials can sometimes be hard to compare because the patients enrolled in those trials start out with different characteristics.…
MS Research Study and Reports

October 21, 2014

Stu’s Views – David Osmond shares his own journey living with Multiple Sclerosis and Kicks off, OUR VOICE in SONG

  • An MS Patients Story
    /
  • Stu's Views and MS News
    /
Back at the ECTRIMS conference in Sept 2014, I and a few others, were invited by Novartis to a dinner…
An MS Patients Story

October 21, 2014

Results from Two Phase III Studies (7mg and 14mg dosages) Added to U.S. Label of Genzyme’s Aubagio

  • MS Drug Therapies
    /
  • Oral MS Medications
    /
Once-daily Aubagio is the only oral treatment to significantly slow progression of disability in two Phase III studies of patients…
MS Drug Therapies

Categories

Latest Blog Posts